Filter Results:
(5,441)
Show Results For
- All HBS Web
(5,441)
- People (18)
- News (2,024)
- Research (2,719)
- Events (7)
- Multimedia (222)
- Faculty Publications (1,992)
Show Results For
- All HBS Web
(5,441)
- People (18)
- News (2,024)
- Research (2,719)
- Events (7)
- Multimedia (222)
- Faculty Publications (1,992)
- February 1985 (Revised January 2024)
- Case
Health Stop (A): What Type of Innovation Is It? And Six Factors Alignment
By: Regina E. Herzlinger, Joyce Lallman, Nancy Kane, Jefferson C. Grahling and James Wallace
How can we evaluate if innovative health care ventures can do good—benefit society—and do well—become financially viable? This question is the topic of the first module in the Innovating In Health Care course book.
This note and case series enables readers to conduct... View Details
Keywords: For-Profit Firms; Business Model; Entrepreneurship; Health Care and Treatment; Strategy; Valuation; Health Industry; Health Industry
Herzlinger, Regina E., Joyce Lallman, Nancy Kane, Jefferson C. Grahling, and James Wallace. "Health Stop (A): What Type of Innovation Is It? And Six Factors Alignment." Harvard Business School Case 185-084, February 1985. (Revised January 2024.)
- March 2015
- Case
The I-PASS Patient Handoff Program
By: Robert S. Huckman and Michael Norris
In 2015, the I-PASS Patient Handoff Program Team, led by six pediatricians around the U.S., had to determine the best way to disseminate their program that had been proven to reduce communication errors in patient handoffs in hospital settings. Should they turn it into... View Details
Keywords: Health Care; Hospitals; Operations Improvement; Entrepreneurship; Health Care and Treatment; Health Industry; United States
Huckman, Robert S., and Michael Norris. "The I-PASS Patient Handoff Program." Harvard Business School Case 615-069, March 2015.
- September 2002 (Revised August 2014)
- Case
Cardinal Health (A): The Medicine Shoppe Acquisition
By: Regina E. Herzlinger, Miguel Abecasis and Brenda Cheng
Robert Walter, the founder and CEO of Cardinal Health, a pharmaceutical distributor, is contemplating the purchase of Medicine Shoppe, a chain of apothecaries. The purchase might be construed as competition against his own drugstore customers. But one of its many... View Details
Keywords: Mergers and Acquisitions; Business Strategy; Competitive Advantage; Distribution Industry; Pharmaceutical Industry; Retail Industry
Herzlinger, Regina E., Miguel Abecasis, and Brenda Cheng. "Cardinal Health (A): The Medicine Shoppe Acquisition." Harvard Business School Case 303-043, September 2002. (Revised August 2014.)
- Web
3.8 Health Insurance | MBA
(HUHS) website for additional information. After hours and during weekends and holidays, medical care can be arranged by calling 617-495-5711 (the HUHS After-Hours Urgent Care Clinic is at the Smith Campus... View Details
- 01 Jan 2020
- News
Changes in Quality of Care after Hospital Mergers and Acquisitions
- December 2011 (Revised December 2011)
- Case
Cancer Treatment Centers of America: Scaling the Mother Standard of Care
By: Rosabeth Moss Kanter and Matthew Bird
The CEO of a private and growing national network of specialty care hospitals focusing on advanced-stage and complex cancer treatments reflected on the firm's past phase of growth before meeting with the company's Chairman and founder to discuss how to further scale... View Details
Keywords: Health Care and Treatment; Business Growth and Maturation; Medical Specialties; Service Delivery; Innovation and Invention; Health Industry
Kanter, Rosabeth Moss, and Matthew Bird. "Cancer Treatment Centers of America: Scaling the Mother Standard of Care." Harvard Business School Case 312-073, December 2011. (Revised December 2011.)
- 10 Aug 2022
- News
Can Amazon Remake Health Care?
- June 2014 (Revised February 2017)
- Case
Kathy Giusti and the Multiple Myeloma Research Foundation
By: Richard G. Hamermesh, Joshua D. Margolis and Matthew G. Preble
What do you do when your rising professional career is cut short by an unexpected cancer diagnosis? Kathy Giusti shifted careers, built a new organization that transformed how cancer research is done, and now faces the challenge of sustaining the organization and its... View Details
Keywords: Philanthropy; Philanthropy Funding; Entrepreneurship; Health Care; Management Styles; Personalized Medicine; Health Care Outcomes; Cancer; Cancer Care In The U.S.; Personal Care; Leadership; Leading Change; Social Entrepreneurship; Philanthropy and Charitable Giving; Health Care and Treatment; Leadership Style; Management Style; Management Skills; Growth and Development Strategy; Business Strategy; Health; Health Industry; United States; Canada; Spain
Hamermesh, Richard G., Joshua D. Margolis, and Matthew G. Preble. "Kathy Giusti and the Multiple Myeloma Research Foundation." Harvard Business School Case 814-026, June 2014. (Revised February 2017.)
- April 1978 (Revised May 1993)
- Teaching Note
Child Care Task Force, Teaching Note
- 1984
- Article
Return to Nursing Home Investment: Issues for Public Policy
By: Carliss Y. Baldwin and Christine E. Bishop
Baldwin, Carliss Y., and Christine E. Bishop. "Return to Nursing Home Investment: Issues for Public Policy." Health Care Financing Review 5, no. 4 (1984).
- January 2001
- Case
Merck Global Health Initiatives (A)
By: James E. Austin, Diana Barrett and James Weber
The case series focuses on Merck's drug donation program and then raises new issues facing management about what to do about HIV/AIDS in Africa given the company's development of a new therapy. Describes collaboration among many parties including the Gates Foundation,... View Details
Keywords: Programs; Philanthropy and Charitable Giving; Health Disorders; Health Care and Treatment; Private Sector; Public Sector; Alliances; Problems and Challenges; Pharmaceutical Industry; Botswana
Austin, James E., Diana Barrett, and James Weber. "Merck Global Health Initiatives (A)." Harvard Business School Case 301-088, January 2001.
- October 2024
- Article
Medicare Part D Protected-Class Policy Is Associated with Lower Drug Rebates
By: Pragya Kakani, Michael Anne Kyle, Amitabh Chandra and Luca Maini
Medicare Part D does not allow plans to exclude drugs in six protected classes from their formularies, which may limit plans’ ability to negotiate rebates and lead to higher spending. We estimated the association between protected-class status, US-level estimated... View Details
Keywords: Insurance; Health Care and Treatment; Governing Rules, Regulations, and Reforms; United States
Kakani, Pragya, Michael Anne Kyle, Amitabh Chandra, and Luca Maini. "Medicare Part D Protected-Class Policy Is Associated with Lower Drug Rebates." Health Affairs 43, no. 10 (October 2024): 1420–1427.
- 08 Apr 2011
- News
Management Matters In Health Care, Too
The road to higher-quality, lower-cost health care leads straight to better management. That was the central message a panel of experts convened by the HBS Health View Details
- Web
Antitrust & Competition Policy - Institute For Strategy And Competitiveness
and new ideas—drive growth in productivity. Antitrust policy, however, remains focused on static goals. While the need for a vigorous antitrust policy is greater than ever, antitrust authorities must use new approaches to evaluating the... View Details
- May 2016
- Case
AbbVie
By: Kevin Schulman, Laura Little, Samyukta Mullangi and Stephen Schleicher
This case focuses on the impact of a novel regulatory pathway, the biosimilars pathway, on the strategy of a major pharmaceutical firm that finds its largest product (60% of revenue) at risk. The case reviews the rationale for the pathway, the emerging biosimilars... View Details
- October 2017
- Case
Pricing PatientPing
By: Frank V. Cespedes, Julia Kelley and Amram Migdal
In 2017, Jay Desai, the CEO of Boston-based health care technology company PatientPing, had to consider a number of interrelated pricing challenges. Founded in late 2013, PatientPing sold a software platform that allowed health care providers to receive real-time... View Details
Keywords: Pricing; Health Tech; Health Technology; Marketing; Sales Process; Sales Strategy; Price; Sales; Marketing Strategy; Health Care and Treatment; Health Industry; Health Industry; Boston; North America; Massachusetts; United States
Cespedes, Frank V., Julia Kelley, and Amram Migdal. "Pricing PatientPing." Harvard Business School Case 818-017, October 2017.
- August 2018
- Article
The Impact of the Entry of Biosimilars: Evidence from Europe
By: Fiona M. Scott Morton, Ariel Dora Stern and Scott Stern
Biologics represent a substantial and growing share of the U.S. drug market. Traditional “small molecule” generics quickly erode the price and share of the branded product upon entry; however, only a few biosimilars have been approved in the U.S. since 2015, thereby... View Details
Keywords: Health Care; Biosimilars; Biologics; Pharmaceutical Competition; Healthcare Spending; Innovation; Health Care and Treatment; Spending; Market Entry and Exit; Competition; Innovation and Invention; Pharmaceutical Industry; United States; Europe
Scott Morton, Fiona M., Ariel Dora Stern, and Scott Stern. "The Impact of the Entry of Biosimilars: Evidence from Europe." Review of Industrial Organization 53, no. 1 (August 2018): 173–210.
- 10 Oct 2023
- Blog Post
Policy Drivers for Environmental Justice: What Businesses Need to Know
communities, combatting climate change and preparing for its effects “across rural, urban, and Tribal areas.”[8] Constellation Energy discusses their EJ policy in the same way, with strong focus on improving equity, reducing impacts on... View Details
- February 2014 (Revised May 2014)
- Case
Hospital Clínic de Barcelona
By: Richard M.J. Bohmer, Daniela Beyersdorfer and Jaume Ribera
Keywords: Health Care; Provider Organizations; Hospital; Organization Structure; Leadership; Organizations; Health; Health Industry; Europe; Spain
Bohmer, Richard M.J., Daniela Beyersdorfer, and Jaume Ribera. "Hospital Clínic de Barcelona." Harvard Business School Case 614-058, February 2014. (Revised May 2014.)